CymaBay Therapeutics Inc. (CBAY) Dropped -6.96% or -0.47 To Price $6.28 On Friday

CymaBay Therapeutics Inc. (CBAY) dropped -6.96% or -0.47 to $6.28. It is about 1.41 million shares traded, which is 79.02% compare to the average total volume 1.78 million. The market cap of CBAY is $431.40 million. The year to date change is -25.24%. The 52 week price range is from $4.82 to $15.0. Price of CBAY have changed -41.36% during last week. It have changed -45.39% over last month, -49.21% over last 3 months, -21.97% over last 6 months and -48.63% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 12.22. It is 94.59% above current price. The 200-day Moving Averages for CBAY is 10.96. It is 74.52% above current price. The 52-week High is 15.0. It is 138.85% from the current price. The 52-week Low is 4.82. It is -23.25% from current price.

There are some statistics of CBAY. It is has market cap $431.40 million. The share outstanding is 68.69 million. The average volume is 1.78 million. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -33.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -31.05%.


Share this post